Clinical Trial Update: Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study [NA]

View source ↗

Summary

A clinical trial comparing anti-PD-1 therapy with and without a postbiotic in treatment-naïve locally advanced or metastatic cutaneous melanoma is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PD-1 inhibitor (antibody) (anti-PD-1 antibody)
• Postbiotic therapy (postbiotic)

Snippet

Sponsor: Azienda Ospedaliera di Perugia | Conditions: Melanoma Metastatic | NA | Status: RECRUITING